Creon 20000 Gastro-resistant Capsules, hard Ireland - English - HPRA (Health Products Regulatory Authority)

creon 20000 gastro-resistant capsules, hard

mylan ire healthcare limited - pancreas powder ph. eur. - gastro-resistant capsule, hard - 20000 - multienzymes (lipase, protease etc.)

Creon 35000 Gastro-resistant Capsules, hard Ireland - English - HPRA (Health Products Regulatory Authority)

creon 35000 gastro-resistant capsules, hard

mylan ire healthcare limited - pancreas powder ph. eur. - gastro-resistant capsule, hard - 35000 - multienzymes (lipase, protease etc.)

Creon 20000 Gastro-resistant Capsules, hard Ireland - English - HPRA (Health Products Regulatory Authority)

creon 20000 gastro-resistant capsules, hard

viatris healthcare limited - pancreas powder ph. eur. - gastro-resistant capsule, hard - multienzymes (lipase, protease etc.)

Creon 35000 Gastro-resistant Capsules, hard Ireland - English - HPRA (Health Products Regulatory Authority)

creon 35000 gastro-resistant capsules, hard

viatris healthcare limited - pancreas powder ph. eur. - gastro-resistant capsule, hard - multienzymes (lipase, protease etc.)

Creon 10000 Capsule coated pellets 150mg Singapore - English - HSA (Health Sciences Authority)

creon 10000 capsule coated pellets 150mg

abbott laboratories (singapore ) private limited - pancreas powder - capsule, coated pellets - 150mg - pancreas powder 150mg

ENZYSTAL P EQUIVALENT TO AMYLASE ACTIVITY 4200 PH. EUR UNITS,  LIPASE ACTIVITY 3500 PH. EUR UNITS AND PROTEASE ACTIVITY 250 PH. Uganda - English - National Drug Authority

enzystal p equivalent to amylase activity 4200 ph. eur units, lipase activity 3500 ph. eur units and protease activity 250 ph.

torrent pharamaceuticals ltd - pancreas powder - oral solid ordinary enteric-coated tablets - equivalent to amylase activity 4200 ph. eur units, lipase activity 3500 ph. eur units and protease activity 250 ph. eur units

Creon 10,000 New Zealand - English - Medsafe (Medicines Safety Authority)

creon 10,000

viatris limited - pancreatin 150mg (amylase 8,000 ph eur u, lipase 10,000 ph eur u, total protease 600 ph eur u.); pancreatin 150mg equivalent to amylase 8,000 ph eur u, lipase 10,000 ph eur u, total protease 600 ph eur u. - modified release capsule - 150 mg - active: pancreatin 150mg (amylase 8,000 ph eur u, lipase 10,000 ph eur u, total protease 600 ph eur u.) excipient: acetone dibutyl phthalate dimeticone gelatin hypromellose phthalate iron oxide black iron oxide red iron oxide yellow liquid paraffin macrogol 4000 propyl alcohol titanium dioxide active: pancreatin 150mg equivalent to amylase 8,000 ph eur u, lipase 10,000 ph eur u, total protease 600 ph eur u. excipient: cetyl alcohol dimeticone ferrosoferric oxide gelatin hypromellose phthalate iron oxide red iron oxide yellow macrogol 4000 sodium laurilsulfate titanium dioxide triethyl citrate - creon is indicated for the treatment of pancreatic exocrine insufficiency (pei) in paediatric and adult patients. pancreatic exocrine insufficiency is often associated with, but not limited to: · cystic fibrosis · chronic pancreatitis · post-pancreatectomy · post-gastrointestinal bypass surgery ,(e.g. billroth ii, gastroenterostomy) · ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm).

Creon 25,000 New Zealand - English - Medsafe (Medicines Safety Authority)

creon 25,000

viatris limited - pancreatin 300mg (amylase 18,000 ph eur u, lipase 25,000 ph eur u, total protease 1,000 ph eur u.); pancreatin 300mg equivalent to amylase 18,000 ph eur u, lipase 25,000 ph eur u, total protease 1,000 ph eur u; pancreatin 300mg equivalent to amylase 18,000 ph eur u, lipase 25,000 ph eur u, total protease 1,000 ph eur u - modified release capsule - 300 mg - active: pancreatin 300mg (amylase 18,000 ph eur u, lipase 25,000 ph eur u, total protease 1,000 ph eur u.) excipient: acetone dibutyl phthalate dimeticone gelatin hypromellose phthalate iron oxide red iron oxide yellow liquid paraffin macrogol 4000 propyl alcohol titanium dioxide active: pancreatin 300mg equivalent to amylase 18,000 ph eur u, lipase 25,000 ph eur u, total protease 1,000 ph eur u excipient: cetyl alcohol dimeticone gelatin hypromellose phthalate iron oxide red iron oxide yellow macrogol 4000 sodium laurilsulfate titanium dioxide triethyl citrate active: pancreatin 300mg equivalent to amylase 18,000 ph eur u, lipase 25,000 ph eur u, total protease 1,000 ph eur u excipient: cetyl alcohol dimeticone gelatin hypromellose phthalate iron oxide red iron oxide yellow macrogol 4000 sodium laurilsulfate triethyl citrate - creon is indicated for the treatment of pancreatic exocrine insufficiency (pei) in paediatric and adult patients. pancreatic exocrine insufficiency is often associated with, but not limited to: · cystic fibrosis · chronic pancreatitis · post-pancreatectomy · post-gastrointestinal bypass surgery ,(e.g. billroth ii, gastroenterostomy) · ductal obstruction of the pancreas or common bile duct (e.g. from neoplasm).

Solu-Cortef Powder for Solution for Injection or Infusion 100mg Ireland - English - HPRA (Health Products Regulatory Authority)

solu-cortef powder for solution for injection or infusion 100mg

pfizer healthcare ireland - hydrocortisone ph. eur. - powder and solvent for solution for injection/infusion - 100 milligram(s) - glucocorticoids; hydrocortisone

Solu-Medrone powder and solvent for solution for injection or concentrate for solution for infusion 40 mg/vial Ireland - English - HPRA (Health Products Regulatory Authority)

solu-medrone powder and solvent for solution for injection or concentrate for solution for infusion 40 mg/vial

pfizer healthcare ireland - methylprednisolone hydrogen succinate ph. eur. - powder and solvent for solution for injection/infusion - 40 milligram/vial - glucocorticoids; methylprednisolone